Subscribe
In addition to the US, high-dose nusinersen (Spinraza; Biogen) is also approved in the European Union, Japan, and Switzerland.
ICYMI: Highlights From MDA 2025
FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population
Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA
Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval
